Related Experiment Videos
Plasma exchange in myasthenia gravis and multiple sclerosis
B Balint1, A Jovicić, S Apostolski
1Military Medical Academy, Institute of Transfusiology, Belgrade.
Vojnosanitetski Pregled
|February 24, 2001
Summary
Therapeutic plasma exchange (TPE) showed positive effects for myasthenia gravis and multiple sclerosis patients when combined with anti-inflammatory and immunosuppressive therapies. Patient selection and timely treatment were key factors for successful outcomes in these neurological conditions.
Area of Science:
- Neurology
- Immunology
- Clinical Medicine
Background:
- Myasthenia gravis and multiple sclerosis are debilitating autoimmune neurological diseases.
- Therapeutic plasma exchange (TPE) is an extracorporeal procedure to remove plasma components.
Purpose of the Study:
- To evaluate the therapeutic efficacy of TPE in patients diagnosed with myasthenia gravis and multiple sclerosis.
- To identify factors influencing TPE treatment outcomes in these conditions.
Main Methods:
- Retrospective analysis of 68 myasthenia gravis and 61 multiple sclerosis patients treated with TPE over twenty years.
- Evaluation of therapeutic effects based on neurological deficit, electrophysiological findings, laboratory analyses, and general patient condition.
Main Results:
- TPE demonstrated significant positive effects in both myasthenia gravis and multiple sclerosis patients.
- Treatment outcomes were influenced by disease nature, stage, patient selection, and timely intervention.
- Combined TPE with anti-inflammatory and immunosuppressive therapies enhanced clinical findings and paraclinical test results.
Conclusions:
- Therapeutic plasma exchange is an effective treatment modality for myasthenia gravis and multiple sclerosis, particularly when integrated with other therapies.
- Careful patient selection and appropriate timing of TPE are crucial for maximizing therapeutic benefits in autoimmune neurological disorders.